Publications

Warren RB, Donnelly K, Kiri S, Taieb V, Slim M, Fahrbach K, Neupane B, Betts M, Armstrong A. Long-Term Efficacy and Safety of Bimekizumab and[...]

By sjmartinez • November 2, 2024

Silverstein J, Karlan B, Herrington N, Konecny G. Antibody-drug conjugates as targeted therapy for treating gynecologic cancers: update 2025. Curr Opin Obstet Gynecol. 2024 Oct[...]

By sjmartinez • November 2, 2024

De La Torre SA, Ibrahim B, Meneses K, Saab S, Shetty A. Impact of phosphatidylethanol in the surveillance for alcohol use in post-liver transplant population:[...]

By sjmartinez • November 1, 2024

Weiner AB, Ells Z, Meyer C, Dahlbom M, Sennung D, Varughese D, Ludwig VB, Carlucci G, Grant R, Czernin J, Calais J, Reiter RE. Clinical[...]

By sjmartinez • November 1, 2024

Gholizadeh S, Exuzides A, Sinnott J, Palmer C, Waltz M, Rose JW, Jolley AM, Behne JM, Behne MK, Blaschke TF, Smith TJ, Lewis KE, Cook[...]

By sjmartinez • November 1, 2024

Brown K, Anderson L. From Mild to Mayhem: A Life-Threatening Exacerbation of Mild Asthma. Cureus. 2024 Sep 30;16(9):e70558. doi: 10.7759/cureus.70558. PMID: 39479137; PMCID: PMC11524714.

By sjmartinez • October 31, 2024

Zhu E, Li YR, Margolis S, Wang J, Wang K, Zhang Y, Wang S, Park J, Zheng C, Yang L, Chu A, Zhang Y, Gao[...]

By sjmartinez • October 31, 2024

Adam SJ, Buchman TG, Currier JS, Draghia-Akli R, Fessel JP, Higgs ES, Hughes EA, LaVange L, Menetski JP, Read SW, Rosenberg Y, Tressler R; ACTIV[...]

By sjmartinez • October 31, 2024

Keshtkar-Jahromi M, Anstrom KJ, Barkauskas C, Brown SM, Daar ES, Fischer W, Gibbs KW, Higgs ES, Hughes MD, Jagannathan P, LaVange L, Lindsell CJ, Nayak[...]

By sjmartinez • October 31, 2024

Feng X, Liu Y, Yang J, Yang S, Zhou Z, Zhou Y, Guo Q. The combined predictive power of the atherogenic index of plasma and[...]

By sjmartinez • October 31, 2024